Carabante-Ocón, FSaez-Lara, EBurgos-Garcia, LVillar-Chamorro, ECasaus-Hazañas, ALuna, SMartínez, C2013-03-052013-03-052007-06-19Carabante-Ocón F, Saez-Lara E, Burgos-Garcia L, Villar-Chamorro E, Casaus-Hazañas A. Luna S, et al. Retreatment with trastuzumab in Her2-positive metastatic breast cancer patients: a clinical study. Breast Cancer Research. 2007 Jun;9 Supplement 1:s17-81465-5411http://hdl.handle.net/10668/804Objective: To study the benefit of trastuzumab in monotherapy or combined with different chemotherapeutic agents in the treatment for Her2+ metastatic breast cancer (MBC) patients after progression on prior trastuzumab therapy.entrastuzumabher2-positivechemotherapiesMBCneoplasias de la mamaRetratamientoMedical Subject Headings::Diseases::Neoplasms::Neoplasms by Site::Breast NeoplasmsMedical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Retreatmentconference posteropen access10.1186/bcr17081465-542X